ABSTRACT. The in vitro activity of 15 antimicrobial agents against clinical isolates of Staphylococcus pseudintermedius, Staphylococcus aureus, Escherichia coli, Pasteurella spp. and Streptococcus canis from dogs was investigated. For Staphylococcus spp., the highest frequency of resistance was observed for penicillin, followed by ampicillin, tetracycline and chloramphenicol. The highest frequency of resistance in E. coli isolates was recorded for tetracycline and streptomycin. Pasteurella spp. and S. canis had the highest resistance rate for tetracycline and chloramphenicol. Most isolates showed full susceptibility to low-level resistance to colistin, florfenicol and fluoroquinolones. Further studies using larger number of isolates from both healthy and diseased dogs would provide a broader picture of antimicrobial resistance at a national level and promote prudent use of antimicrobial agents in companion animals. Antibacterial drug resistance continues to increase worldwide, with some pathogenic bacteria exhibiting resistance to virtually all available drugs [29] . While there are considerable, though often fragmented, data on the quantities of antimicrobial drug use and resistance in bacteria of food animal origin, useful data on antimicrobial drug use and resistance in companion animals are relatively scarce [22, 24] . The most frequent bacterial infections in dogs include skin, ear, wound, gastrointestinal and urinary tract infections. Staphylococcus pseudintermedius, Escherichia coli, Pseudomonas aeruginosa, Streptococcus spp. and Proteus spp. are among the most frequently encountered bacterial pathogens in companion animal veterinary practice. The antimicrobial drug susceptibilities of canine isolates have been reported [1, 7, 9, 23] , most of which have also zoonotic significance. S. pseudintermedius is the principal cause of pyoderma and otitis in canine [24] . Although it had been misidentified for decades as S. intermedius, recent analyses by molecular phylogenetic and PCR-restriction fragment length polymorphism (PCR-RFLP) approaches indicated that S. pseudintermedius, not S. intermedius, is the major canine pyoderma pathogen [6, 23, 25] , and it has already been proposed that all strains from dogs identified by traditional means be reported as S. pseudintermedius [6, 11] . Increasing resistance of this organism and failures to treat canine pyoderma or otitis with a number of antibacterial agents, including fluoroquinolones were reported recently [6, 30] . Furthermore, cross-resistance between fluoroquinolones and other antibacterial agents and zoonotic transmission of both meticillin-susceptible and meticillin-resistant S. pseudintermedius between dogs and humans have been concerns recently [30, 31] . Resistance in canine E. coli isolates to a wide range of antimicrobial agents, including fluoroquinolones, is increasingly reported [2] . Furthermore, the chemical and structural similarities between veterinary and human-use drugs and the close phylogenetic relationships between E. coli isolates from dogs and man have raised concerns of cross-resistance and potential spread of resistant zoonotic bacteria [15] . P. multocida is among the most common bacteria that infect humans during dog bites [18, 23, 29] . Therefore, a high incidence of antimicrobial drug resistance in dogs could have implications of zoonotic transmission of resistant bacteria. In the present study, we report the in vitro activity of 15 antimicrobial agents against S. pseudintermedius, S. aureus, E. coli, Pasteurella spp. and Streptococcus canis clinical isolates from dogs in Korea.
Antibacterial drug resistance continues to increase worldwide, with some pathogenic bacteria exhibiting resistance to virtually all available drugs [29] . While there are considerable, though often fragmented, data on the quantities of antimicrobial drug use and resistance in bacteria of food animal origin, useful data on antimicrobial drug use and resistance in companion animals are relatively scarce [22, 24] . The most frequent bacterial infections in dogs include skin, ear, wound, gastrointestinal and urinary tract infections. Staphylococcus pseudintermedius, Escherichia coli, Pseudomonas aeruginosa, Streptococcus spp. and Proteus spp. are among the most frequently encountered bacterial pathogens in companion animal veterinary practice. The antimicrobial drug susceptibilities of canine isolates have been reported [1, 7, 9, 23] , most of which have also zoonotic significance. S. pseudintermedius is the principal cause of pyoderma and otitis in canine [24] . Although it had been misidentified for decades as S. intermedius, recent analyses by molecular phylogenetic and PCR-restriction fragment length polymorphism (PCR-RFLP) approaches indicated that S. pseudintermedius, not S. intermedius, is the major canine pyoderma pathogen [6, 23, 25] , and it has already been proposed that all strains from dogs identified by traditional means be reported as S. pseudintermedius [6, 11] . Increasing resistance of this organism and failures to treat canine pyoderma or otitis with a number of antibacterial agents, including fluoroquinolones were reported recently [6, 30] . Furthermore, cross-resistance between fluoroquinolones and other antibacterial agents and zoonotic transmission of both meticillin-susceptible and meticillin-resistant S. pseudintermedius between dogs and humans have been concerns recently [30, 31] . Resistance in canine E. coli isolates to a wide range of antimicrobial agents, including fluoroquinolones, is increasingly reported [2] . Furthermore, the chemical and structural similarities between veterinary and human-use drugs and the close phylogenetic relationships between E. coli isolates from dogs and man have raised concerns of cross-resistance and potential spread of resistant zoonotic bacteria [15] . P. multocida is among the most common bacteria that infect humans during dog bites [18, 23, 29] . Therefore, a high incidence of antimicrobial drug resistance in dogs could have implications of zoonotic transmission of resistant bacteria. In the present study, we report the in vitro activity of 15 antimicrobial agents against S. pseudintermedius, S. aureus, E. coli, Pasteurella spp. and Streptococcus canis clinical isolates from dogs in Korea.
The sources of all bacteria in this study were diagnostic specimens of diseased dogs. The specimens were collected from 50 dogs that visited the veterinary teaching hospital of Kyungpook National University or were samples collected by Gyeongbuk Veterinary Service Laboratory from 119 sick dogs owned by private dog breeders located in Kyungpook Province, Korea. All samples were collected between 2006 and 2008 from adult and juvenile dogs of both sexes. The animals selected for this study had no known history of prior antibiotic therapy. Inclusion of bacterial strains was based on site of isolation and a one sample per animal basis. The hemolytic staphylococci, of which 67 were S. pseudintermedius and 32 were S. aureus, were mainly derived from swab samples from skin lesions of dogs with clinical signs of pyoderma and also from the ear (mostly Otitis externa). The Pasteurella spp. (n=13) and Streptococcus spp. (n=18) were obtained from throat and nasal swabs of the respiratory tract of sick dogs. The E. coli isolates (n=37) were obtained from skin lesions and fecal swabs of diarrheic dogs. Handling of the pathogen culture and identification were based on standard microbiological procedures [13, 14, 21] , which included use of API identification kits. The characterizations of the isolates were first performed with phenotypic *CorrespondenCe to: park, S.-C., College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Korea. e-mail: parksch@knu.ac.kr ©2012 The Japanese Society of Veterinary Science appearance and biochemical tests, and then API identification commercial kits and genotypic identification with PCR were applied as required. Bacteria were identified from their appearance on agar media, swarming, hemolysis, odor, cell morphology, catalase and oxidase reaction and Gram properties. The identification kits used were API ID 32E for E. coli, API 20NE for Pasteurella spp., API ID 32 STAPH for S. intermedius and API rapid ID 32 STREP for Streptococcus canis (bioMérieux, Marcy-l'Etoile, France). Identification of S. canis was further confirmed with a positive test for reaction with Lancefield's group G antiserum (Oxoid, Hampshire, U.K.). S. pseudintermedius was initially differentiated from S. aureus by exhibiting lack of β-hemolysis on sheep blood agar, lack of yellow colony pigment, lack of acid production from D-mannitol and negative reaction for the Voges-Proskauer test. Further confirmation was made by PCR tests based on the nuc gene of the S. intermedius group and S. aureus and a conserved region of 16S rDNA (as a positive control) using previously reported primers and optimal PCR cycling conditions [3, 19] . A total of 15 antimicrobial agents that are approved or/ and represent commonly used drug classes in Korea were investigated. All antimicrobial agents were obtained in powder form, and stock and working solutions were prepared weekly according to the manufacturers' instructions. These included ampicillin, ciprofloxacin, chloramphenicol, colistin, enrofloxacin, gentamicin, norfloxacin, penicillin, spectinomycin, streptomycin, tetracycline and tiamulin (Becton, Dickinson and company, Heidelberg, Germany), orbifloxacin (Samyang Anipharm, Seoul, Korea) and florfenicol and tylosin (Shinil Biogen, Anyang, Korea). Susceptibility to antimicrobial agents was determined using the Clinical and Laboratory Standards Institute (CLSI) broth micro-dilution method [4, 27] . E. coli ATCC 25922, S. aureus ATCC 29213, S. intermedius ATCC 29663 and S. pneumoniae ATCC 49619 were included as quality control strains. The minimum inhibitory concentration (MIC) interpretative criteria were taken from the CLSI (formerly NCCLS), when available, or adopted from published sources [4, 7, 21, 22, 28] . Only resistant isolates were counted as resistant, whereas intermediate ones were counted as susceptible.
The MICs of the tested antimicrobial agents that inhibited 50 and 90% of the clinical isolates (MIC 50 and MIC 90 , respectively), the MIC ranges and the frequency of resistant isolates are presented in Table 1 .
Most S. pseudintermedius isolates were resistant to one or more antibacterial agents. The highest frequency of resistance was recorded for penicillin (61.25%), ampicillin (40.3%), tetracycline (37.3%) and chloramphenicol (20.9%), while resistance to fluoroquinolones, gentamicin and other antibacterial agents was low (<10%). Similarly, a high rate of S. pseudintermedius resistance for penicillin, ampicillin and tetracycline was reported in other countries [7, 8, 13, 21, 22] . The resistance to chloramphenicol of canine S. pseudintermedius strains (18%) isolated from a different region in Korea [17] was also comparable to our study. However, the resistance to tetracycline reported there was very high (90%) compared with that (37%) in our study, possibly due to a different locality, different investigation period or a shift in antimicrobial drug use. All S. aureus isolates were resistant to penicillin and had a high frequency of resistance to other antibacterial agents, including chloramphenicol (47.1%), ampicillin (44.1%), tetracycline (38.2%), gentamicin (35.3%) and spectinomycin (32.4%). Like S. pseudintermedius isolates, the resistance rates of S. aureus strains for fluoroquinolones and florfenicol were low.
Resistance rates among E. coli isolates were the highest for tetracycline, streptomycin and ampicillin. Low frequencies of resistance (<10%) to all other antimicrobial agents, including fluoroquinolones, were recorded. A high prevalence of tetracycline, streptomycin and ampicillin resistance among E. coli isolates from animals has been reported [1, 10, 22] . E. coli isolates from diarrheic pigs in Korea [16] had a higher frequency of resistance to tetracycline (97.1%) and streptomycin (99%), while the rate of resistance to ampicillin (27.1%) was comparable to our investigation. A moderate to high level resistance to these antibacterial agents was also reported for E. coli strains isolated from feces of healthy dogs [5] , cattle and pigs [20, 25] .
Pasteurellae species are commensal organisms in the upper respiratory and gastrointestinal tracts of domestic and wild animals and birds. For example, P. multocida is found in the oropharynx of 70 to 90% of domestic cats and 25 to 50% of dogs [29] . In the present study, 30.8% of Pasteurella spp. were resistant to tetracycline. The resistance rate for chloramphenicol was 23.7%, although all isolates were susceptible to florfenicol. This may indicate the infrequent use of florfenicol in canine veterinary practice, as the drug is not approved for this species. Orbifloxacin showed the highest resistance (15.4%) among the fluoroquinolones. All Pasteurella isolates were susceptible to gentamicin, and a low level of resistance to the remaining antimicrobial agents was observed. The high tetracycline resistance in this study was in agreement with previous reports [12, 22] . However, resistance to this drug by Pasteurella isolates in the current study was high compared with previous studies, which have generally reported susceptibility to many antimicrobial agents including penicillins, aminoglycosides and fluoroquinolones [12, 22, 26] .
A significant proportion of S. canis isolates were resistant to one or more antimicrobial agents, including tetracycline (50%), chloramphenicol (44.4%) and gentamicin (33.3%). Resistance to fluoroquinolones was also observed, with the highest rate being 16.7% for orbifloxacin. Penicillin and ampicillin were the most active agents against S. canis isolates. Similarly, high susceptibility of Streptococcus spp. to penicillins and resistance to tetracycline and gentamicin were reported [22, 27] .
In the present study, we investigated the susceptibilities of some of the most frequently isolated pathogens from various infections in dogs. There are some potential limitations of this study. First, bacterial samples were collected either from clinical cases with no known history of prior antibiotic therapy or from private dog farms where the use of antimicrobial agents is relatively less regulated. Hence, our study could not rule out the possibility of prior exposure to antimicrobial agents that may select for bacterial strains with multiple-antimicrobial resistant phenotypes [7, 24] . Furthermore, although one of the highest rates of multidrug resistance in Korea, which is associated with the lack of strict regulation of antibacterial drugs in veterinary use and self-medication of drugs by some dog breeders and pet owners, has already been reported [30] , the relatively small number of bacterial isolates tested here might not be representative of the general population of dogs in other regions. Therefore, it is essential to extend similar investigations using bacterial isolates from both healthy and diseased dogs in all geographical regions to obtain a broader picture of antimicrobial resistance at a national level and promote prudent use of antimicrobial agents in companion animals. 
